BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28316135)

  • 21. Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas.
    Moore GW; Kumano O
    J Thromb Haemost; 2020 Feb; 18(2):439-444. PubMed ID: 31663664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixing studies for lupus anticoagulant: mostly no, sometimes yes.
    Moore GW
    Clin Chem Lab Med; 2020 Mar; 58(4):492-495. PubMed ID: 31874095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium-dependent activated partial thromboplastin time assay-Simple method for lupus anticoagulant detection.
    Tokutake T; Ieko M; Naito S; Yoshida M; Baba H; Kobayashi H; Ishida F
    Int J Lab Hematol; 2020 Feb; 42(1):46-51. PubMed ID: 31821738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
    Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
    J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
    Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
    Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
    Efthymiou M; Mackie IJ; Lane PJ; Andrade D; Willis R; Erkan D; Sciascia S; Krillis S; Bison E; Borges Galhardo Vendramini M; Romay-Penabad Z; Qi M; Tektonidou M; Ugarte A; Chighizola C; Belmont HM; Aguirre MA; Ji L; Branch DW; de Jesus G; Fortin PR; Andreoli L; Petri M; Cervera R; Rodriguez E; Knight JS; Atsumi T; Vega J; Sevim E; Bertolaccini ML; Pengo V; Cohen H;
    J Thromb Haemost; 2019 Dec; 17(12):2069-2080. PubMed ID: 31364274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Brighton T; Pasalic L
    Int J Lab Hematol; 2022 Jun; 44(3):654-665. PubMed ID: 35234361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
    Moore GW
    Methods Mol Biol; 2023; 2663():275-288. PubMed ID: 37204717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant.
    Gardiner C; MacKie IJ; Malia RG; Jones DW; Winter M; Leeming D; Taberner DA; Machin SJ; Greaves M
    Br J Haematol; 2000 Dec; 111(4):1230-5. PubMed ID: 11167766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of standard plasma for diagnosis and quantitation of lupus anticoagulants.
    Schjetlein R; Wisløff F
    Thromb Res; 1993 Nov; 72(4):287-94. PubMed ID: 8303668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin.
    Liestøl S; Jacobsen EM; Wisløff F
    Thromb Res; 2002 Jan; 105(2):177-82. PubMed ID: 11958810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference ranges of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.
    Gerbutavicius R; Fareed J; Messmore HL; Iqbal O; Wehrmacher WH; Hoppensteadt DA; Demir M; Piccolo P; Ahmad S; Ma Q; Griniute R
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):51-9. PubMed ID: 11991240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.